Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Journal of Pharmaceutical Sciences|January 1, 1986
A modified, sensitive liquid chromatographic method for measurement of propranolol with fluorescence detectionR P Koshakji, A J WoodToxicology and Applied Pharmacology|March 30, 1984
Studies on the metabolic fate of [14C]2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the mouseR P Koshakji, R D Harbison, M T BushJournal of Environmental Science and Health. Part C: Environmental Health Sciences|January 1, 1979
Metabolism and distribution of 2,4,5-trichlorophenoxyacetic acid (2,4,5-T) in pregnant miceR P Koshakji, M T Bush, R D HarbisonClinical Pharmacology and Therapeutics|July 1, 1986
Enprostil, in contrast to cimetidine, does not inhibit propranolol metabolismC S Reilly, J Biollaz, R P Koshakji, et al.Anesthesiology|July 1, 1985
The effect of halothane on drug disposition: contribution of changes in intrinsic drug metabolizing capacity and hepatic blood flowC S Reilly, A J Wood, R P Koshakji, et al.Clinical Pharmacology and Therapeutics|November 1, 1985
Ultra-short-acting beta-blockade: a comparison with conventional beta-blockadeC S Reilly, M Wood, R P Koshakji, et al.Journal of Pharmaceutical Sciences|September 1, 1989
Simultaneous determination of propranolol enantiomers in plasma by high-performance liquid chromatography with fluorescence detectionC Prakash, R P Koshakji, A J Wood, et al.Clinical Pharmacology and Therapeutics|July 1, 1984
Polymorphic ability to metabolize propranolol alters 4-hydroxypropranolol levels but not beta blockadeT C Raghuram, R P Koshakji, G R Wilkinson, et al.Clinical Pharmacology and Therapeutics|June 1, 1989
Interindividual differences in beta-receptor density contribute to variability in response to beta-adrenoceptor antagonistsH H Zhou, D J Silberstein, R P Koshakji, et al.Clinical Pharmacology and Therapeutics|April 1, 1989
Influence of debrisoquin phenotype on the inducibility of propranolol metabolismO Shaheen, J Biollaz, R P Koshakji, et al.Pageof 2